MENU
+Compare
SKIN
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$0.98
Change
+$0.03 (+3.16%)
Capitalization
528.89M

SKIN Beauty Health Company (The) Forecast, Technical & Fundamental Analysis

The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products... Show more

SKIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SKIN with price predictions
Apr 23, 2025

SKIN sees MACD Histogram crosses below signal line

SKIN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 07, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SKIN as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SKIN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SKIN entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SKIN's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SKIN advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

SKIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.905) is normal, around the industry mean (17.380). P/E Ratio (53.476) is within average values for comparable stocks, (204.360). Projected Growth (PEG Ratio) (0.858) is also within normal values, averaging (3.832). Dividend Yield (0.000) settles around the average of (0.107) among similar stocks. P/S Ratio (1.418) is also within normal values, averaging (116.662).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SKIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SKIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

View a ticker or compare two or three
SKIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SKIN is expected to report earnings to rise 61.75% to -12 cents per share on May 08

Beauty Health Company (The) SKIN Stock Earnings Reports
Q1'25
Est.
$-0.13
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.06
Q2'24
Missed
by $0.08
Q1'24
Est.
$-0.10
The last earnings report on March 12 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 379.22K shares outstanding, the current market capitalization sits at 528.89M.
A.I. Advisor
published General Information

General Information

Industry HouseholdPersonalCare

Profile
Fundamentals
Details
Industry
N/A
Address
2165 Spring Street
Phone
+1 800 603-4996
Employees
881
Web
https://www.beautyhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POICX10.66N/A
N/A
Virtus Tactical Allocation C
MENYX8.52N/A
N/A
Madison Covered Call & Equity Income Y
NPNCX44.39N/A
N/A
Neuberger Berman Large Cap Value C
AXVIX15.58N/A
N/A
Acclivity Small Cap Value I
TRZNX16.48N/A
N/A
T. Rowe Price New Asia Z

SKIN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SKIN has been loosely correlated with RPHCF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SKIN jumps, then RPHCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKIN
1D Price
Change %
SKIN100%
+7.00%
RPHCF - SKIN
63%
Loosely correlated
N/A
SPB - SKIN
33%
Poorly correlated
+2.93%
EL - SKIN
29%
Poorly correlated
+2.36%
COTY - SKIN
29%
Poorly correlated
+2.28%
IPAR - SKIN
28%
Poorly correlated
+1.79%
More